Release: MESA AIR GROUP ALERT Bragar Eagel & Squire, P.C. is Investigating Mesa Air Group, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

Release

MESA AIR GROUP ALERT Bragar Eagel & Squire, P.C. is Investigating Mesa Air Group, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

1 April 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Mesa Air Group, Inc. (NASDAQ: MESA) on behalf of Mesa stockholders. Our investigation concerns whether Mesa has violated the federal securities laws and/or engaged in other unlawful business practices.

Read full release.

Release: DOUYU ALERT Bragar Eagel & Squire, P.C. Announces That a Securities Class Action Lawsuit Has Been Filed Against DouYu International Holdings Limited and Encourages Investors to Contact the Firm

Release

DOUYU ALERT: Bragar Eagel & Squire, P.C. Announces That a Securities Class Action Lawsuit Has Been Filed Against DouYu International Holdings Limited and Encourages Investors to Contact the Firm

25 March 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors that purchased DouYu International Holdings Limited (NASDAQ: DOYU) securities pursuant and/or traceable to DouYu’s July 16, 2019 initial public offering (the “IPO” or “Offering”). Investors have until May 26, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.

Release: FORTY SEVEN ALERT Bragar Eagel & Squire, P.C. Investigates Sale of FTSV and Encourages Investors to Contact the Firm

Release

FORTY SEVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FTSV and Encourages Investors to Contact the Firm

17 March 2020

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Forty Seven, Inc. (NASDAQ: FTSV) breached their fiduciary duties or violated the federal securities laws in connection with the company’s proposed merger with Gilead Sciences, Inc.

Read full release.

Release: DEADLINE ALERT Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Release

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

11 March 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) securities between January 8, 2019 and February 26, 2020 (the “Class Period”). Investors have until March 16, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.

Article: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Canaan, Inc. and Encourages Investors to Contact the Firm

Article - Media

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Canaan, Inc. and Encourages Investors to Contact the Firm

Business Wire, 5 March 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the District of Oregon on behalf of investors that purchased Canaan, Inc. (NASDAQ: CAN) securities pursuant or traceable to the Company’s initial public offering, which commenced on or about November 20, 2019 (the “IPO” or “Offering”). Investors have until May 4, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full article.

Release: MGP INGREDIENTS ALERT Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against MGP Ingredients, Inc. and Encourages Investors to Contact the Firm

Release

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against MGP Ingredients, Inc. and Encourages Investors to Contact the Firm

28 February 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the District of Kansas on behalf of investors that purchased MGP Ingredients, Inc. (NASDAQ: MGPI) securities between February 27, 2019 and February 25, 2020 (the “Class Period”). Investors have until April 28, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.

Release: GRAND CANYON EDUCATION ALERT Bragar Eagel & Squire, P.C. is Investigating Grand Canyon Education, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

Release

GRAND CANYON EDUCATION ALERT Bragar Eagel & Squire, P.C. is Investigating Grand Canyon Education, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

28 January 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against Grand Canyon Education, Inc. (NASDAQ:LOPE) on behalf of Grand Canyon Education stockholders. Our investigation concerns whether Grand Canyon Education has violated the federal securities laws and/or engaged in other unlawful business practices.

Read full release.

 

Release: DEADLINE ALERT Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm

Release

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm

19 September 2019

Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all investors that purchased Karyopharm, Inc. (NASDAQ: KPTI) securities between March 2, 2017 to February 22, 2019 (the “Class Period”). Investors have until September 23, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.

Release: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Abiomed, Inc. (NASDAQ: AMBD) and Encourages Abiomed Investors to Contact the Firm

Release

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Abiomed, Inc. (NASDAQ: AMBD) and Encourages Abiomed Investors to Contact the Firm

7 August 2019

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Abiomed, Inc. (NASDAQ: AMBD) securities between January 31, 2019 and July 31, 2019 (the “Class Period”).  Investors have until October 7, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.